NCT04683276

Brief Summary

In the current study, the investigators described the results of a randomized, comparative clinical trial that was conducted to study the impact of the size of internal limiting membrane (ILM) inverted flap on rate and timing of idiopathic macular hole closure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 19, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 24, 2020

Completed
Last Updated

December 29, 2020

Status Verified

December 1, 2020

Enrollment Period

1.2 years

First QC Date

December 19, 2020

Last Update Submit

December 24, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • rate of macular hole closure

    defined as the proportion of the eyes with complete MH closure based on SD-OCT findings

    6 months

Secondary Outcomes (2)

  • timing of MH closure

    6 months

  • BCVA

    6 months

Study Arms (4)

small flap medium-sized macular hole (SFMM)

ACTIVE COMPARATOR

small flap (1-2 disc-diameter) was performed in medium sized macular hole (250-400 um)

Procedure: pars plana vitrectomy with ILM inverted flap

large flap medium-sized macular hole (LFMM)

ACTIVE COMPARATOR

large flap (3-4 disc-diameter) was performed in medium sized macular hole (250-400 um)

Procedure: pars plana vitrectomy with ILM inverted flap

small flap large-sized macular hole (SFLM)

ACTIVE COMPARATOR

small flap (1-2 disc-diameter) was performed in Large sized macular hole (\>400 um)

Procedure: pars plana vitrectomy with ILM inverted flap

large flap Large-sized macular hole (LFLM)

ACTIVE COMPARATOR

large flap (3-4 disc-diameter) was performed in large sized macular hole (\>400 um)

Procedure: pars plana vitrectomy with ILM inverted flap

Interventions

Complete vitrectomy was done with the aid of triamcinolone acetonide followed by fluid-air exchange. Staining of the ILM was carried with 0.05% solution of Brilliant Blue dye (BBG), (Ocublue plus, Aurolab, India) for 30 seconds, ILM peeling was proceeded leaving a circle of ILM measuring approximately 1-2 DD in SF groups and \>2 to 4DD in LF group, centered around the MH. The ILM outside the parafoveal area was peeled to the arcade. The ILM around the hole was then detached from the retina up to the edge of the hole. The ILM flap around the edge of the hole was inverted over the MH using a scraper.

large flap Large-sized macular hole (LFLM)large flap medium-sized macular hole (LFMM)small flap large-sized macular hole (SFLM)small flap medium-sized macular hole (SFMM)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Eyes with stage 4 idiopathic MHs with a diameter \>250µm on spectral domain optical coherence tomography (SD-OCT)

You may not qualify if:

  • traumatic MH
  • myopic MHs,
  • MH secondary to retinal detachment,
  • long-standing MH\> 12 months
  • previous retinal surgeries
  • high myopia with an axial length \> 26.0 mm
  • other ocular pathologies interfering with the interpretation of the OCT reports.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ophthalmic center

Al Mansurah, Dakahelia, 35516, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2020

First Posted

December 24, 2020

Study Start

February 1, 2019

Primary Completion

April 1, 2020

Study Completion

October 1, 2020

Last Updated

December 29, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations